The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Ribonucleic Acid (RNA) Splicing Modulators Market Expected To Change From 2026 To 2030?
The market for ribonucleic acid (RNA) splicing modulators has seen substantial growth in recent years. This market is anticipated to expand from $2.69 billion in 2025 to $3.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. The expansion observed historically is attributable to factors like the rising occurrence of genetic disorders, developments in molecular biology techniques, the proliferation of oncology therapeutics, increased research and development investments, and the adoption of antisense oligonucleotides.
The ribonucleic acid (RNA) splicing modulators market size is projected to undergo significant expansion in the upcoming years. It is anticipated to grow to $5.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.2%. This growth over the forecast period is fueled by the creation of AI-driven splicing modulators, the wider application of personalized medicine approaches, an increase in collaborations between pharmaceutical and biotechnology companies, enhancements in delivery mechanisms, and regulatory approvals for new therapies. Prominent trends for the forecast period include specific RNA splicing therapies, individualized genetic medicine, high-throughput screening platforms, the integration of bioinformatics tools, and advanced molecular modeling.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Ribonucleic Acid (RNA) Splicing Modulators Market Forward?
The escalating occurrence of genetic disorders is projected to propel the expansion of the ribonucleic acid (RNA) splicing modulators market in the future. Genetic disorders are conditions or illnesses resulting from irregularities in an individual’s DNA, encompassing mutations, deletions, or chromosomal alterations that impair normal biological functions. The increase in these disorders, attributed to heightened awareness and sophisticated diagnostic capabilities, facilitates the identification of more cases, enabling earlier detection and management of inherited conditions. RNA splicing modulators play a role in managing genetic disorders by targeting and rectifying aberrant RNA splicing events, thereby offering a therapeutic potential to address or control the genetic mutations responsible for these conditions. For example, in May 2024, the National Health Service, a UK-based government department, stated that 17,000 people live with sickle cell disease, an inherited genetic blood disorder, with roughly 250 new cases diagnosed each year. Thus, the rising prevalence of genetic disorders is a key factor driving the growth of the ribonucleic acid (RNA) splicing modulators market.
Which Segments Define The Ribonucleic Acid (RNA) Splicing Modulators Market Segment Structure?
The ribonucleic acid (RNA) splicing modulators market covered in this report is segmented –
1) By Product Type: Small Molecule Modulators, Antisense Oligonucleotides, Small Interfering Ribonucleic Acid, Other Product Types
2) By Route Of Administration: Subcutaneous, Intravenous, Intrathecal Central Nervous System Adjacent
3) By Application: Cancer, Genetic Disorders, Neurological Disorders, Other Applications
4) By End-User: Pharmaceutical Companies, Research Institutes, Hospitals And Clinics, Other End Users
Subsegments:
1) By Small Molecule Modulators: Splicing Factor Inhibitors, Ribonucleic Acid Binding Modulators, Kinase Modulators Affecting Splicing, Pre- Messenger Ribonucleic Acid Processing Modulators, Exon Skipping Enhancers
2) By Antisense Oligonucleotides: Exon Skipping Antisense Oligonucleotides, Splice Site Modifying Antisense Oligonucleotides, Intronic Targeting Antisense Oligonucleotides, Messenger Ribonucleic Acid Degradation Inducing Antisense Oligonucleotides, Gene Expression Modulating Antisense Oligonucleotides
3) By Small Interfering Ribonucleic Acid: Exon Skipping Small Interfering Ribonucleic Acid, Splice Site Small Interfering Ribonucleic Acid, Intronic Targeting Small Interfering Ribonucleic Acid, Pre- Messenger Ribonucleic Acid Processing Small Interfering Ribonucleic Acid, Gene Silencing Small Interfering Ribonucleic Acid
4) By Other Product Types: Ribonucleoprotein Complex Modulators, Spliceosome Assembly Modulators, Ribonucleic Acid Editing Enzyme Modulators, Long Non-Coding Ribonucleic Acid Modulators, Messenger Ribonucleic Acid Modulators
What Trends Are Affecting The Growth Of The Ribonucleic Acid (RNA) Splicing Modulators Market?
Leading companies in the ribonucleic acid (RNA) splicing modulators market are concentrating on advancements in RNA-targeted drug discovery platforms, such as RNA-directed small molecule splicing modulators, with the goal of improving efficacy, enhancing safety, and addressing unmet needs in neurodegenerative diseases. RNA-directed small molecule splicing modulators are compact compounds that attach to RNA to modify pre-mRNA splicing, thereby correcting or adjusting splicing patterns to treat genetic diseases or cancers. For instance, in September 2025, Skyhawk Therapeutics, a US-based biotechnology company, released positive interim data from its Phase 1 clinical trial of SKY-0515 for Huntington’s disease. This is an orally administered, investigational small molecule RNA splicing modifier created through the company’s SKYSTAR platform. It exhibited dose-dependent reductions of mutant huntingtin protein (up to 62%) and PMS1 mRNA in patients, along with excellent brain penetration and a favorable safety profile, indicating a potential dual-mechanism strategy to target core pathogenic processes without operator intervention.
Who Are The Established Players Within The Ribonucleic Acid (RNA) Splicing Modulators Market?
Major companies operating in the ribonucleic acid (RNA) splicing modulators market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, Biogen Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Abivax SA, Twist Bioscience Corporation, Wave Life Sciences Ltd, Arrakis Therapeutics Inc., Remix Therapeutics Inc., Anima Biotech Inc., Rgenta Therapeutics Inc., Avidity Biosciences Inc., Skyhawk Therapeutics Inc., Stoke Therapeutics Inc., Accent Therapeutics Inc., Chordia Therapeutics Inc., Panorama Medicine Inc., Serna Therapeutics Inc., Ribometrix Inc., Envisagenics Inc., Dyne Therapeutics Inc.
Get The Full Ribonucleic Acid (RNA) Splicing Modulators Market Report:
Which Region Accounts For The Largest Portion Of The Ribonucleic Acid (RNA) Splicing Modulators Market?
North America was the largest region in the ribonucleic acid (RNA) splicing modulators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) splicing modulators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Ribonucleic Acid (RNA) Splicing Modulators Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Splicing Modulators Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model